| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 09/27/2000 | CN1267510A Application of cation mono-benzol nitrophenylamine in keratin fiber dyeing dye composition and dyeing method |
| 09/27/2000 | CN1056835C Novel selective aromatase inhibiting compounds |
| 09/27/2000 | CN1056833C Process for the sulphinylation of heterocyclic compound |
| 09/26/2000 | US6124465 Farnesyl transferase inhibitors, their preparation, the pharmaceutical compositions which contain them and their use in the preparation of medicaments |
| 09/26/2000 | US6124461 Compounds, compositions, and methods for treating erectile dysfunction |
| 09/26/2000 | US6124361 Bicyclo[3.1.0]hexanes and related compounds |
| 09/26/2000 | US6124313 Imidazopyridine azolidinones |
| 09/26/2000 | US6124251 Toilet bowl cleaning tablet |
| 09/26/2000 | US6124250 Method of making highly alkaline solid cleaning compositions |
| 09/21/2000 | WO2000055155A2 Heterocyclic compounds as adenosine deaminase inhibitors |
| 09/21/2000 | WO2000055126A2 N-cyanomethylamides as protease inhibitors |
| 09/21/2000 | WO2000055125A2 N-cyanomethyl amides as protease inhibitors |
| 09/21/2000 | WO2000054729A2 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 09/21/2000 | WO2000039077A3 Thyroid receptor ligands |
| 09/21/2000 | CA2368148A1 Novel compounds and compositions as protease inhibitors |
| 09/21/2000 | CA2368122A1 Novel compounds and compositions as protease inhibitors |
| 09/21/2000 | CA2367461A1 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 09/20/2000 | EP1036065A1 Substituted imidazole derivatives having agonist-like activity at alpha 2b or 2b/2c adrenergic receptors |
| 09/20/2000 | EP1036059A1 Adamantane derivatives |
| 09/20/2000 | EP1036058A1 Adamantane derivatives |
| 09/20/2000 | EP0772602B1 Process for preparing 1,3-disubstituted imidazolidinones |
| 09/20/2000 | EP0705816B1 Benzene derivative useful for ischemic diseases |
| 09/20/2000 | CN1266847A Process for preparing ketone condensate of L-(+)-2-amino-1-p-nitrophenyl-1,3-propanediol |
| 09/20/2000 | CN1056608C Pseudodipeptide product having imidazole group and applications |
| 09/20/2000 | CN1056602C Esters and amides as PLAZ inhibitors |
| 09/19/2000 | US6121457 Compositions and methods using novel substituted imidazolium lipids |
| 09/19/2000 | US6121322 Antiinflammatory agents |
| 09/19/2000 | US6121303 Such as 4-((3,4-dihydroxy-5-nitrophenyl)methylidene)-2,5-imidazolidindione; medicinal antioxidants for treatment or prevention of tissue damage caused by lipid peroxidation |
| 09/19/2000 | US6121295 Treating diabetic complications by administering an insulin sensitivity enhancer such as pioglitazone in combination with a statin compound such as pravastatin |
| 09/19/2000 | US6121294 Reducing the amount of therapeutic agents administered to a diabetic patient by administering an insulin sensitivity enhancer in combination with an alpha-glucosidase inhibitor as said therapeutic agents; side effect reduction |
| 09/19/2000 | US6121260 Appetite stimulation with dosage of neuropeptide y (npy) receptor agonist |
| 09/19/2000 | US6120696 Proton conductors in liquid form |
| 09/14/2000 | WO2000053613A1 Chemical vapor deposition precursors and thermochromic materials thereof |
| 09/14/2000 | WO2000053596A2 Imidazole compounds as histamine h3 ligands |
| 09/14/2000 | WO2000053582A1 HETEROCYCLIC COMPOUNDS HAVING EFFECT OF ACTIVATING NICOTINIC ACETYLCHOLINE α4β2 RECEPTOR |
| 09/14/2000 | CA2366260A1 Heterocyclic compounds having effect of activating .alpha.4.beta.2 nicotinic acetylcholine receptors |
| 09/14/2000 | CA2362319A1 Imidazole compounds as histamine h3 ligands |
| 09/13/2000 | EP1034162A1 9,10-dihydro-9,10-ethanoanthracene derivatives as phospholipase inhibitors |
| 09/13/2000 | EP1033910A1 Dipeptide apoptosis inhibitors and the use thereof |
| 09/13/2000 | EP0915858B1 Intermediates for the preparation of 2-imidazoline-5-ones |
| 09/13/2000 | EP0778883B1 Quarternary substituted bleach activators |
| 09/13/2000 | CN1266368A Heterocyclic vinylethers against neurological disorders |
| 09/12/2000 | US6118010 Catalytic reduction of the 1-alkoxycarbonyl-3-oxo-3-phenylpropyl derivative |
| 09/12/2000 | US6118001 Anticancer agent; antiarthritic agent |
| 09/12/2000 | US6117940 Solid phase synthesis of compounds such as the imidazoles, benzodiazepines, pyrazines, and steroid mimics. |
| 09/08/2000 | WO2000052134A2 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | WO2000051993A2 Dihetero-substituted metalloprotease inhibitors |
| 09/08/2000 | WO2000051971A1 Oxamic acids and derivatives as thyroid receptor ligands |
| 09/08/2000 | WO2000051614A1 Inhibitors of prenyl-protein transferases |
| 09/08/2000 | WO2000051612A1 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | WO2000051611A1 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | WO2000051547A2 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | CA2366954A1 Dihetero-substituted metalloprotease inhibitors |
| 09/08/2000 | CA2363169A1 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | CA2362778A1 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | CA2362495A1 Inhibitors of prenyl-protein transferases |
| 09/08/2000 | CA2362494A1 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | CA2362493A1 Inhibitors of prenyl-protein transferase |
| 09/06/2000 | EP1033731A2 Photo-electrochemical cell containing an electrolyte comprising a liquid crystal compound |
| 09/06/2000 | EP1033367A2 Process for the preparation of optically active triazole derivatives and their imidazolidin-2-one intermediates |
| 09/06/2000 | EP1032559A1 Aminoalkylphenol derivatives and related compounds |
| 09/06/2000 | EP1032556A1 Pharmaceutically active compounds and methods of use |
| 09/06/2000 | CN1265647A Acrylic metalloprotease inhibitor |
| 09/06/2000 | CN1265394A Compound as intermediates for use in preparation of optically active 2-imidazoline-5-one or 2-imidazoline-5-thionone derivatives |
| 09/06/2000 | CN1056140C Biphenyl derivatives, their preparation and theirt use for treatment of hypertension and cardiac disease |
| 09/06/2000 | CN1056138C Process for preparing allophanamide compound |
| 09/05/2000 | US6114539 Reacting imidazole derivative with sulfur with a strong base in presence of diluent, and then hydrolyzing the product with water, or with sulfur in presence of diluent having high boiling point; controlling undesired microorganism in plants |
| 09/05/2000 | US6114390 An argininamide or ornithinamide compound as treating memory loss, migraine, sleep disorders, pain, cardiovascular diseases, subarachnoidal bleeding, vascular-hypertrophic changes, cerebral and coronary vasospasms |
| 09/05/2000 | US6114334 Piperazine derivatives as therapeutic agents |
| 09/05/2000 | US6114325 1,2-di-substituted benzene-carboxamide derivative, hair growth promoter and external composition for skin using the same |
| 08/31/2000 | WO2000050431A1 Platinum (ii) compounds |
| 08/31/2000 | WO2000050392A1 2-mercaptocarboxylic acid derivatives |
| 08/31/2000 | WO2000050390A1 N-substituted arylsulfonylamino hydroxamic acids useful as inhibitors of c-proteinase and for treating or preventing disorders related to unregulated collagen production |
| 08/31/2000 | WO2000019994A9 Estrogen receptor ligands |
| 08/31/2000 | CA2364804A1 N-substituted arylsulfonylamino hydroxamic acids useful as inhibitors of c-proteinase and for treating or preventing disorders related to unregulated collagen production |
| 08/31/2000 | CA2364712A1 Platinum (ii) compounds |
| 08/30/2000 | EP1031563A1 Sulfonyl derivatives |
| 08/30/2000 | EP1030836A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 08/30/2000 | EP0749418B1 L-n6 -(1-iminoethyl)lysine derivatives useful as nitric oxide synthase inhibitors |
| 08/30/2000 | CN1265096A Hydrazine derivatives |
| 08/30/2000 | CN1265033A Certain diarylimidaozle derivatives, new class of NPY speific ligands |
| 08/29/2000 | US6110944 LTA4, hydrolase inhibitors |
| 08/29/2000 | US6110933 Amino acid derivatives and their use as phospholipase A2 inhibitor |
| 08/29/2000 | US6110922 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 08/24/2000 | WO2000049031A2 Method for isolating nucleic acids |
| 08/24/2000 | WO2000049007A1 Acetamido acetonitrile derivatives as inhibitors of cathepsin l and/or cathepsin s |
| 08/24/2000 | WO2000048994A1 Thioamide derivatives |
| 08/24/2000 | WO2000048988A1 Phenylalaninol derivatives |
| 08/24/2000 | WO2000048987A1 Novel substituted 3-phenoxy and 3-phenylalkyloxy-2-phenyl-propylamines |
| 08/24/2000 | WO2000048974A1 Stabilised compositions of o- and n-vinyl compounds and the use of ammonium salts as stabilisers |
| 08/24/2000 | WO2000048597A1 Systemic use of 5-ht3 receptor antagonists against rheumatic inflammatory processes |
| 08/24/2000 | DE19907385A1 New 3-(phenoxy or phenylalkoxy)-2-phenyl-propylamines, useful for treating e.g. arrhythmia, spasms, pain or neurodegenerative diseases, are tension-dependent sodium channel blockers |
| 08/24/2000 | DE19907023A1 Isolation of nucleic acids, useful for e.g. genetic diagnosis by amplification, by adsorption onto polymeric beads at neutral or acidic pH then release at basic pH |
| 08/24/2000 | CA2362979A1 Method for isolating nucleic acids |
| 08/23/2000 | EP1029851A1 Piperazine compounds and medicinal use thereof |
| 08/23/2000 | EP1029073A1 Method and agent for determining an enzymatic activity such as deaminase |
| 08/23/2000 | EP1028948A1 Phenyl-alkyl-imidazoles as h3 receptor antagonists |
| 08/23/2000 | EP1028947A1 H3 receptor ligands of the phenyl-alkyl-imidazoles type |
| 08/23/2000 | EP1028942A2 Dipeptide nitriles |
| 08/23/2000 | CN1264385A Novel 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and compositions containing same |